Live-Attenuated Influenza Vaccine and Long-Term Asthma Outcomes
نویسندگان
چکیده
منابع مشابه
Maternal outcomes among pregnant women receiving live attenuated influenza vaccine
BACKGROUND Although the live attenuated influenza vaccine (LAIV) prescribing information contains warnings/precautions against use during pregnancy, administration of LAIV to pregnant women does occur. Data regarding maternal outcomes after LAIV administration during pregnancy are limited. OBJECTIVES Maternal outcomes after LAIV vaccination during pregnancy were examined. METHODS Data from ...
متن کاملLive attenuated influenza vaccine--a review.
Owing to the variability of influenza viruses, vaccine composition needs to be up-dated annually. As many variables can influence their efficacy, vaccines are still considered "sub-optimal". Many studies have been carried out in recent years to improve vaccines. In particular, researchers and vaccine-producing corporations have focused on developing a live vaccine. Among the candidate vaccines,...
متن کاملSeasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.
BACKGROUND Few observational studies have evaluated the relative effectiveness of live attenuated (LAIV) and inactivated (IIV) influenza vaccines against medically attended laboratory-confirmed influenza. METHODS We analyzed US Influenza Vaccine Effectiveness Network data from participants aged 2 to 17 years during 4 seasons (2010-2011 through 2013-2014) to compare relative effectiveness of L...
متن کاملAcceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
BACKGROUND The burden of influenza is increasingly recognised in Africa. The WHO recommends introducing influenza vaccination to high-risk groups: pregnant women, children <5 years, and the elderly. The Gambia currently has no influenza vaccination policy, but the NASIMMUNE study, a clinical trial of intranasal live attenuated influenza vaccines (LAIV) in young children provided an opportunity ...
متن کاملUse of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing
In their review of live attenuated influenza vaccine (LAIV), Esposito et al. stated that in the US and Europe, LAIV is not recommended for children and adults with asthma and children younger than 5 years of age with a history of recurrent wheezing. While this statement is accurate for the US, it is not accurate for the European Union. The European Medicines Agency approved LAIV for use in chil...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Open Forum Infectious Diseases
سال: 2015
ISSN: 2328-8957
DOI: 10.1093/ofid/ofv133.1452